SAN FRANCISCO — On Sunday, Alnylam, the gene-silencing company that notched one gigantic accomplishment after another over ...
Stoke Therapeutics and the FDA were unable to reach agreement on an expedited submission for the company’s severe epilepsy ...
The super-sized gathering of the biopharma universe known as JPM is important, but it’s not going to make or break the year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback